589 results on '"Corte, Tamera J."'
Search Results
2. Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare Variants.
3. Cluster analysis of blood biomarkers to identify molecular patterns in pulmonary fibrosis: assessment of a multicentre, prospective, observational cohort with independent validation
4. The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness study
5. The 1-min sit-to-stand test as a screening tool to assess exercise-induced oxygen desaturation in normoxemic people with interstitial lung disease
6. Disease Behaviour Classification: A pragmatic model for predicting outcomes in Interstitial Lung Disease
7. Detection and Early Referral of Patients With Interstitial Lung Abnormalities An Expert Survey Initiative
8. The relative contribution of co-morbidities to health-related quality of life of people with idiopathic pulmonary fibrosis using the Assessment of Quality of Life-8-Dimension multi-attribute utility instrument
9. Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA1) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD)
10. Assessment of health-related quality of life in Australian patients with idiopathic pulmonary fibrosis: a comparison of the EQ-5D-5L and the AQoL-8D
11. Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management
12. Sex- and Race-Based Differences in the Treatment of Interstitial Lung Diseases in North America and Australasia
13. Machine learning in radiology: the new frontier in interstitial lung diseases
14. Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis
15. Pirfenidone in Unclassifiable Interstitial Lung Disease: A Subgroup Analysis by Concomitant Mycophenolate Mofetil and/or Previous Corticosteroid Use
16. Mortality surrogates in combined pulmonary fibrosis and emphysema
17. Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis: The Randomized Phase III STARSCAPE Trial
18. Detection and Early Referral of Patients With Interstitial Lung Abnormalities: An Expert Survey Initiative
19. Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine.
20. Identification of Diagnostic Criteria for Chronic Hypersensitivity Pneumonitis. An International Modified Delphi Survey
21. The Physiology of Interstitial Lung Disease
22. Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank
23. Editorial: Epidemiology and risk factors for interstitial lung diseases
24. Exertional Desaturation During the 6-Minute Walk Test vs Daily Life in People With Fibrotic Interstitial Lung Disease
25. Multiple serum biomarkers associate with mortality and interstitial lung disease progression in systemic sclerosis
26. Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis: The Randomized Phase III STARSCAPE Trial
27. The impact of air pollution on interstitial lung disease: a systematic review and meta-analysis
28. Diagnosis of myositis-associated interstitial lung disease: Utility of the myositis autoantibody line immunoassay
29. The impact of idiopathic pulmonary fibrosis on health state utility values: evidence from Australia
30. Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study
31. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial
32. Mortality surrogates in combined pulmonary fibrosis and emphysema
33. Fibroblast Foci and Patchy Fibrosis Do Not Separate Usual Interstitial Pneumonia From Fibrotic Hypersensitivity Pneumonitis in Transbronchial Cryobiopsies
34. Nutritional status and quality of life in interstitial lung disease: a prospective cohort study
35. There is detectable variation in the lipidomic profile between stable and progressive patients with idiopathic pulmonary fibrosis (IPF)
36. Fibulin-1 Predicts Disease Progression in Patients With Idiopathic Pulmonary Fibrosis
37. Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study
38. Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision.
39. Drug-induced interstitial lung disease: a narrative review of a clinical conundrum.
40. Interstitial pneumonia with autoimmune features: from research classification to diagnosis
41. Occupational interstitial lung diseases
42. Current and Emerging Drug Therapies for Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD)
43. Palliative care in interstitial lung disease: living well
44. The Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Cardiac Sarcoidosis
45. Novel diagnostic techniques in interstitial lung disease
46. Long‐term exposure to low concentrations of air pollution and decline in lung function in people with idiopathic pulmonary fibrosis: Evidence from Australia.
47. Mapping EQ5D utilities from forced vital capacity and diffusing capacity in fibrotic interstitial lung disease
48. Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry
49. A Composite Serum Biomarker Index for the Diagnosis of Systemic Sclerosis–Associated Interstitial Lung Disease: A Multicenter, Observational Cohort Study.
50. The relative contribution of co-morbidities to health-related quality of life of people with idiopathic pulmonary fibrosis using the Assessment of Quality of Life-8-Dimension multi-attribute utility instrument
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.